Showing results (1-10 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
Selective Bcl-2 inhibition to treat chronic lymphocytic leukemia and non-Hodgkin lymphomaSamuel Y Ng, Matthew S DavidsClinical Advances in Hematology & Oncology : H&O|July 9, 2014
Prescribing for older patients with cancerBeatriz Korc-Grodzicki, Manpreet K Boparai, Stuart M LichtmanClinical Advances in Hematology & Oncology : H&O|September 10, 2015
Review of treatment options for oligometastatic non-small cell lung cancerMichael R Folkert, Robert TimmermanClinical Advances in Hematology & Oncology : H&O|September 10, 2015
How we treat systemic light-chain amyloidosisChakra P Chaulagain, Raymond L ComenzoClinical Advances in Hematology & Oncology : H&O|September 10, 2015
The effect of cancer treatment on cognitive functionArash Asher, Jamie S MyersClinical Advances in Hematology & Oncology : H&O|March 24, 2016
Current Options for Third-Line Treatment of Metastatic Colorectal CancerAxel Grothey, John L Marshall, Tara E SeeryClinical Advances in Hematology & Oncology : H&O|March 24, 2016
Novel Approaches for the Interim Management of Relapsed/Refractory Acute Lymphocytic Leukemia: A Case-Study CompendiumEunice S Wang, Elias J Jabbour, Dan DouerClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Moving toward targeted therapies in acute myeloid leukemiaWeiqiang Gao, Elihu EsteyClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? No, EGFR TKIs should be reserved for patients with EGFR mutationsGregory J RielyClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Upper tract urothelial carcinoma: special considerationsRyan Hutchinson, Ahmed Haddad, Arthur Sagalowsky, et al.Pageof 68